On ECHEMI
Home > Drugs > Heilongjiang Jiangshi Pharmaceutical Co., Ltd.
Heilongjiang Jiangshi Pharmaceutical Co., Ltd.
  • Founded in:

    1998-07-27
  • Country:

    China China
  • Address:

    No. 2 Weihai Road, Pingfang Economic and Technological Development Zone, Harbin City, Heilongjiang Province
  • Tax NO.:

    91230199702846035D
  • Registered Funds:

    5 million yuan
  • Website:

  • Email:

Related Drugs
Compound bovine fetal liver extract tablets
This product is a compound preparation, whose ingredients are bovine fetal liver extract (containing a variety of liver-derived peptide cytokines such as IGF1, FGF, TGFS, HGF), vitamin B12, and inositol.
Name Description Content CAS NO. Registered Holders
Bovine fetal liver extract

It contains a variety of liver-derived peptide cytokines such as IGF1, FGF, TGFs, and HGF, which increase the activity of ATP synthase by inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, promote the cell's uptake and utilization of glucose, and increase energy synthesis; promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition.

More

It contains a variety of liver-derived peptide cytokines such as IGF1, FGF, TGFs, and HGF, which increase the activity of ATP synthase by inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, promote the cell's uptake and utilization of glucose, and increase energy synthesis; promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition.

0
Vitamin B12

This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the cell's uptake and utilization of glucose, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition.

More

This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the cell's uptake and utilization of glucose, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition.

68-19-9 16
Inositol

It participates in inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, increasing the activity of ATP synthase, promoting the uptake and utilization of glucose by cells, and increasing energy synthesis.

More

It participates in inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, increasing the activity of ATP synthase, promoting the uptake and utilization of glucose by cells, and increasing energy synthesis.

87-89-8 8
Yangchunyuye
Deer antler, epimedium, Morinda officinalis, Rehmannia root, Codonopsis pilosula, Astragalus membranaceus, Lycium barbarum, Cnidium monnieri, antler glue, tortoise shell, Asparagus cochinchinensis; auxiliary ingredients are honey and preservative (ethyl paraben).
Name Description Content CAS NO. Registered Holders
Cervi Cornu Panto Trichum

0
Epimedium P.E Icariin 10%,20% HPLC

0
Morinda officinalis sky white matrix sample

0
REHMANNIAE RADIX PRAEPARATA

0
Codonopsis

0
Astragali Radix

0
lycii Fructus

0
Cnidii Fructus

0
CERVI CORNUS COLLA

0
CHINEMYSREEVESII(GRAY)#

0
Asparagus cochinchinensis

0
Honey

8028-66-8 89
ethyl salicylate

118-61-6 14
Myo-aminoglycan for injection
This product contains a variety of cardiovascular active substances, the main components of which include atrial peptides, calcitonin gene-related peptides and nucleotides (nucleosides) such as adenosine triphosphate (adenosine), in addition to more than 20 amino acids and their metabolic intermediates.
Name Description Content CAS NO. Registered Holders
atriopeptin II

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

More

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

98084-69-6 0
calcitonin gene related peptide

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

More

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

0
Adenosine triphosphate

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

More

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

56-65-5 2
5-Methyl-2'-deoxycytidine

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

More

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

838-07-3 0
Amino acids and their metabolic intermediates

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

More

It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

0
Thymosin enteric-coated tablets
The main ingredient of this product is thymosin, a biologically active polypeptide extracted from the thymus of healthy calves.
Name Description Content CAS NO. Registered Holders
Thymosin

Immunomodulatory drugs have the function of regulating and enhancing the cellular immune function of the human body. They can promote the maturation of T lymphocytes, increase the secretion of various lymphokines by T cells (such as: α, γ interferon, interleukin 2 and interleukin 3), increase the level of lymphokine receptors on T cells, activate T4 helper cells to enhance lymphocyte response, affect the chemotaxis of NK precursor cells and enhance the body's ability to resist radiation.

More

Immunomodulatory drugs have the function of regulating and enhancing the cellular immune function of the human body. They can promote the maturation of T lymphocytes, increase the secretion of various lymphokines by T cells (such as: α, γ interferon, interleukin 2 and interleukin 3), increase the level of lymphokine receptors on T cells, activate T4 helper cells to enhance lymphocyte response, affect the chemotaxis of NK precursor cells and enhance the body's ability to resist radiation.

0
Ethylenediamine diacetate for injection
Ethylenediamine diacetate.
Name Description Content CAS NO. Registered Holders
Clotrimazole

1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.

More

1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.